4
Changes in Ownership
Moleculin Biotech, Inc. Filed Acc 0001437749-26-037582
Chief Financial Officer gave up 89 shares (to pay taxes)
- Chief Financial Officer acquired 362 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Foster Jonathan P. · Chief Financial Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-11-16 | Exercise or conversion : show line 1 in the form | +362 | 20,595 | D | ||
| 2026-11-16 | Shares withheld for taxes : show line 2 in the form | −89 | $7.14 | $635 | 20,506 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Underlying | Owned after | D/I |
|---|---|---|---|---|---|
| 2026-11-16 | Exercise or conversion : show line 3 in the form Restricted Stock Units | −362 | 362 | 70,492 | D |
Loading xslF345X06/rdgdoc.xml…